Jackson Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,612
Closed -$2.3M 92
2022
Q3
$2.3M Buy
52,612
+30,935
+143% +$1.5M 0.45% 52
2022
Q2
$1.14M Sell
21,677
-35,143
-62% -$1.79M 0.53% 45
2022
Q1
$2.94M Sell
56,820
-113
-0.2% -$5.86K 0.41% 62
2021
Q4
$3.36M Buy
56,933
+1,637
+3% +$81.1K 0.43% 68
2021
Q3
$11K Buy
55,296
+968
+2% +$42.9K 0.13% 68
2021
Q2
$2.13M Buy
54,328
+1,743
+3% +$67.8K 0.27% 83
2021
Q1
$1.91M Buy
52,585
+4,336
+9% +$154K 0.29% 84
2020
Q4
$1.78M Buy
48,249
+1,397
+3% +$51.2K 0.24% 87
2020
Q3
$1.63M Buy
46,852
+5,498
+13% +$193K 0.24% 83
2020
Q2
$1.28M Buy
41,354
+3,355
+9% +$114K 0.23% 85
2020
Q1
$1.37M Sell
37,999
-19,475
-34% -$664K 0.29% 70
2019
Q4
$2.17M Buy
57,474
+6,302
+12% +$224K 0.36% 76
2019
Q3
$1.74M Buy
51,172
+15,558
+44% +$566K 0.36% 73
2019
Q2
$1.48M Buy
35,614
+1,090
+3% +$43.3K 0.32% 73
2019
Q1
$1.39M Buy
+34,524
New +$1.38M 0.34% 72
2017
Q1
Sell
-60,261
Closed -$1.83M 71
2016
Q4
$1.83M Buy
60,261
+1,973
+3% +$60.2K 0.72% 30
2016
Q3
$1.81M Buy
58,288
+4,414
+8% +$148K 0.68% 31
2016
Q2
$1.8M Buy
53,874
+1,881
+4% +$60K 0.67% 34
2016
Q1
$1.55M Sell
51,993
-1,882
-3% -$53.8K 0.6% 41
2015
Q4
$1.58M Buy
53,875
+225
+0.4% +$7.08K 0.63% 43
2015
Q3
$1.6M Sell
53,650
-2,954
-5% -$94.7K 0.57% 48
2015
Q2
$1.8M Buy
+56,604
New +$1.84M 0.61% 43

Other funds holding PFE

Jackson Wealth Management's PFE Position: Q4 2022 in Review

Jackson Wealth Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 52,612 shares — an estimated $2.3M sold.

Jackson Wealth Management first reported a position in PFE in Q2 2015 and held it in 22 quarters. The position peaked at $3.36M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Jackson Wealth Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Jackson Wealth Management sold 52,612 Pfizer shares in Q4 2022, an estimated $2.3M.
  • Jackson Wealth Management first reported a position in Pfizer in Q2 2015 and held it in 22 quarters.
  • Jackson Wealth Management's Pfizer position peaked at $3.36M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Jackson Wealth Management's 13F filing for Q4 2022, filed 10 Feb 2023.